Countries where authors publish in Expert Opinion on Investigational Drugs
Since Specialization
Citations
This map shows the geographic impact of research published in Expert Opinion on Investigational Drugs. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Expert Opinion on Investigational Drugs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Expert Opinion on Investigational Drugs more than expected).
Fields of papers published in Expert Opinion on Investigational Drugs
This network shows the impact of papers published in Expert Opinion on Investigational Drugs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Expert Opinion on Investigational Drugs.
About Expert Opinion on Investigational Drugs
The 4.1k papers published in Expert Opinion on Investigational Drugs in the last decades have received a total of 113.2k indexed citations . Papers published in Expert Opinion on Investigational Drugs usually cover Oncology (507 papers), Endocrinology, Diabetes and Metabolism (309 papers), Hematology (207 papers), Pharmacology (291 papers) and Hepatology (123 papers) specifically the topics of Diabetes Treatment and Management (95 papers), Asthma and respiratory diseases (94 papers), Monoclonal and Polyclonal Antibodies Research (88 papers), HIV/AIDS drug development and treatment (82 papers), Lipoproteins and Cardiovascular Health (72 papers), Neuroscience and Neuropharmacology Research (70 papers), Cancer Treatment and Pharmacology (68 papers) and HER2/EGFR in Cancer Research (67 papers). The most active scholars publishing in Expert Opinion on Investigational Drugs are Sheila Anne Doggrell, Claudiu Trandafir Supuran, Paul A. Marks, Michael L. Salgaller, Daniel J. Drucker, Lloyd R. Kèlland, Kewal K. Jain, Peter Norman, N H Georgopapadakou and Theresa J. Smith.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.